XML 87 R76.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation (Details 1)
 3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
StockBased Compensation  
Weighted average exercised price outstanding beg of period | $ / shares $ 6.47
Weighted average exercised price options granted | $ / shares 0.41
Weighted average exercised price canceled/forfeited | $ / shares 0.45
Weighted average exercised price outstanding end of period | $ / shares 2.52
Weighted average exercised price vested and expected to vest end of the period | $ / shares 2.52
Weighted average exercised price exercisable at March 31, 2024 | $ / shares $ 6.76
Weighted Average Remaining Life end of period exercisable, begin 6 years 1 month 2 days
Weighted Average Remaining Life end of period exercisable, end 8 years 7 months 2 days
Weighted Average Remaining Life Vested and expected to vest end of period 8 years 7 months 2 days
Weighted Average Remaining Life end of period 6 years 4 months 17 days
Stock option outstanding | shares 214,652
Stock option options granted | shares 435,000
Stock option canceled/forfeited | shares (35,059)
Stock option outstanding end of the period | shares 614,593
Vested and expected to vest at March 31, 2024 | shares 614,593
Exercisable at March 31, 2024 | shares 204,593
Aggregate Intrinsic Value outstanding | $ $ 32,260
Aggregate Intrinsic Value, Vested and expected to vest at March 31, 2024 | $ $ 32,260